Taiwan’s Food and Drug Administration has granted emergency use authorization (EUA) for Moderna’s second-generation COVID-19 vaccines for adults aged 18 years old and above after a meeting of experts Friday.
The recommended interval for the updated vaccine, which targets both the original virus from 2020 and the Omicron subvariant BA. 1, will be three months from previous doses, according the Taiwan FDA.
Taiwan is expected to decide on how many doses of the updated vaccine it will buy from Moderna on Sept. 5, Victor Wang (???), head of the Central Epidemic Commander Center, said earlier Friday.
Source: Focus Taiwan News Channel